UniProt P20231
P20231
P20231 (UniProt P20231): 19 experimental structures on GenesisL1, 1 ligand bound. Binding sites, pockets, druggability and 3D structures in GL1X.
- UniProt
- P20231
- Experimental structures
- 19
- Predicted models
- 0
- Ligands
- 1
Structures
19 records of P20231 in the MolNFT archive: 19 experimental, 0 predicted.
| Entry | Title | Method | Chains | Ligands | Pockets |
|---|---|---|---|---|---|
| 1A0L | Human beta-tryptase: a ring-like tetramer with active sites facing a central pore | x-ray diffraction | A, B, C, D | — | — |
| 1A0L | Human beta-tryptase: a ring-like tetramer with active sites facing a central pore | x-ray diffraction | A, B, C, D | — | — |
| 2BM2 | human beta-II tryptase in complex with 4-(3-Aminomethyl-phenyl)- piperidin-1-yl-(5-phenethyl… | x-ray diffraction | A, B, C, D | — | — |
| 2BM2 | Human beta-II tryptase in complex with 4-(3-aminomethyl-phenyl)- piperidin-1-yl-(5-phenethyl… | x-ray diffraction | A, B, C, D | — | — |
| 2FPZ | Human tryptase with 2-amino benzimidazole | x-ray diffraction | A, B, C, D | — | — |
| 2FPZ | Human tryptase with 2-amino benzimidazole | x-ray diffraction | A, B, C, D | — | — |
| 2FS8 | Human beta-tryptase II with inhibitor CRA-29382 | x-ray diffraction | A, B, C, D | — | — |
| 2FS8 | Human beta-tryptase II with inhibitor cra-29382 | x-ray diffraction | A, B, C, D | — | — |
| 2FS9 | Human beta tryptase II with inhibitor CRA-28427 | x-ray diffraction | A, B, C, D | — | — |
| 2FS9 | Human beta tryptase II with inhibitor cra-28427 | x-ray diffraction | A, B, C, D | — | — |
| 2FWW | human beta-tryptase II complexed with 4-piperidinebutyrate to make acylenzyme | x-ray diffraction | A, B, C, D | — | — |
| 2FWW | Human beta-tryptase II complexed with 4-piperidinebutyrate to make acylenzyme | x-ray diffraction | A, B, C, D | — | — |
| 2FXR | human beta tryptase II complexed with activated ketone inhibitor CRA-29382 | x-ray diffraction | A, B, C, D | — | — |
| 2FXR | Human beta tryptase II complexed with activated ketone inhibitor cra- 29382 | x-ray diffraction | A, B, C, D | — | — |
| 2GDD | Human beta II tryptase with inhibitor CRA-27592 | x-ray diffraction | A, B, C, D | — | — |
| 2GDD | Human beta II tryptase with inhibitor cra-27592 | x-ray diffraction | A, B, C, D | — | — |
| 5F03 | TRYPTASE B2 IN COMPLEX WITH 5-(3-Aminomethyl-phenoxymethyl)-3-[3-(2-chloro-pyridin-3-ylethynyl)-phen… | x-ray diffraction | A, B | 5TA | — |
| 5F03 | Tryptase B2 in complex with 5-(3-aminomethyl-phenoxymethyl)-3-[3-(2… | x-ray diffraction | A, B | — | — |
| P20231 | AlphaFold monomer V2.0 prediction for tryptase beta-2 (P20231) | — | — | — |
Ligands
- 5TA · (5~{S})-5-[[3-(aminomethyl)phenoxy]methyl]-3-[3-[2-(2-chloranylpyridin-3-yl)ethynyl]phenyl]-1,3-oxazolidin-2-one · in 1 record
Elsewhere
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.